ARTICLE | Company News
ImmunoPharmaceutics Inc. news
June 7, 1993 7:00 AM UTC
ImmunoPharmaceutics Inc. ImmunoPharmaceutics Inc. received a $50,000 Phase I SBIR grant to use its bioreactive compound mapping technology in the development of safe insecticides targeted at certain ...